Dronedarone
CAS 141626-36-0
In Stock
Dronedarone
Cat. No. ANT-DRD-00CAS 141626-36-0In Stock
Technical Data
Cat. No.ANT-DRD-00
CAS141626-36-0
Mol. FormulaC31H44N2O5S
Mol. Weight556.76 g/mol
IUPACN-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide
SMILESCCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC
InChIInChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3
InChI KeyZQTNQVWKHCQYLQ-UHFFFAOYSA-N
Purity99%
Description
Overview
Dronedarone, sold under the brand name Multaq, is a medication by Sanofi-Aventis, mainly for the indication of cardiac arrhythmias. It was approved by the FDA on July 2, 2009
Anant Labs manufacture and furnish high quality Dronedarone impurities for global markets. Our Dronedarone EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
N-[2-Butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]benzofuran-5-yl]methanesulfonamideDronedarone141626-36-0SR 33589SR 33589BDronedaronaSR33589N-(2-Butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamideMethanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]-N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide
